-
1
-
-
33645678801
-
Metastatic malignant melanoma of the gastrointestinal tract
-
Liang KV, Sanderson SO, Nowakowski GS, Arora AS: Metastatic malignant melanoma of the gastrointestinal tract. Mayo Clin Proc 2006;81(4):511-6.
-
(2006)
Mayo Clin Proc
, vol.81
, Issue.4
, pp. 511-516
-
-
Liang, K.V.1
Sanderson, S.O.2
Nowakowski, G.S.3
Arora, A.S.4
-
2
-
-
4444370752
-
Contemporary surgical treatment of advanced-stage melanoma
-
Essner R, Lee JH, Wanek LA, Itakura H, Morton DL: Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004;139(9):961-6.
-
(2004)
Arch Surg
, vol.139
, Issue.9
, pp. 961-966
-
-
Essner, R.1
Lee, J.H.2
Wanek, L.A.3
Itakura, H.4
Morton, D.L.5
-
3
-
-
33749128689
-
Overall and progression-free survival in metastatic melanoma: Analysis of a single-institution database
-
Khan MA, Andrews S, Ismail-Khan R, Munster PN, Brem S, King J, Reintgen DS, Sondak VK, Daud AI: Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database. Cancer Control 2006;13(3):211-7.
-
(2006)
Cancer Control
, vol.13
, Issue.3
, pp. 211-217
-
-
Khan, M.A.1
Andrews, S.2
Ismail-Khan, R.3
Munster, P.N.4
Brem, S.5
King, J.6
Reintgen, D.S.7
Sondak, V.K.8
Daud, A.I.9
-
4
-
-
0034911117
-
Surgical resection for metastatic melanoma to the liver: The John Wayne Cancer Institute and Sidney Melanoma Unit experience
-
Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL: Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sidney Melanoma Unit experience. Arch Surg 2001;136(8):950-5.
-
(2001)
Arch Surg
, vol.136
, Issue.8
, pp. 950-955
-
-
Rose, D.M.1
Essner, R.2
Hughes, T.M.3
Tang, P.C.4
Bilchik, A.5
Wanek, L.A.6
Thompson, J.F.7
Morton, D.L.8
-
5
-
-
0032752646
-
Long-term survival after complete resection of melanoma metastatic to the adrenal gland
-
Haigh PI, Essner R, Wardlaw JC, Stern SL, Morton DL: Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol 1999;6(7):633-39.
-
(1999)
Ann Surg Oncol
, vol.6
, Issue.7
, pp. 633-639
-
-
Haigh, P.I.1
Essner, R.2
Wardlaw, J.C.3
Stern, S.L.4
Morton, D.L.5
-
6
-
-
33644969811
-
Multiorgan resection (including the pancreas) for metastasis of cutaneous malignant melanoma. JOP
-
234-40
-
Belágyi T, Zsoldos P, Makay R, Issekutz A, Oláh A: Multiorgan resection (including the pancreas) for metastasis of cutaneous malignant melanoma. JOP 2006;7(2):234-40.
-
(2006)
, vol.7
, Issue.2
-
-
Belágyi, T.1
Zsoldos, P.2
Makay, R.3
Issekutz, A.4
Oláh, A.5
-
7
-
-
33846429178
-
the Groupe d'Oncologie Thoracique des Cliniques Saint-Luc: Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience
-
Poncelet AJ, Lurquin A, Weynand B, Humblet Y, Noirhomme P; the Groupe d'Oncologie Thoracique des Cliniques Saint-Luc: Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience. Eur J Cardiothorac Surg 2007;31(2):173-80.
-
(2007)
Eur J Cardiothorac Surg
, vol.31
, Issue.2
, pp. 173-180
-
-
Poncelet, A.J.1
Lurquin, A.2
Weynand, B.3
Humblet, Y.4
Noirhomme, P.5
-
8
-
-
33749130405
-
Survival after surgical resection of isolated pulmonary metastases from malignant melanoma
-
Andrews S, Robinson L, Cantor A, DeConti RC: Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control 2006;13(3):218-23.
-
(2006)
Cancer Control
, vol.13
, Issue.3
, pp. 218-223
-
-
Andrews, S.1
Robinson, L.2
Cantor, A.3
DeConti, R.C.4
-
9
-
-
0029759722
-
Surgical resection for melanoma metastatic to the gastrointestinal tract
-
Ollila DW, Essner R, Wanek LA, Morton DL: Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 1996;131(9):975-9;979-80.
-
(1996)
Arch Surg
, vol.131
, Issue.9
-
-
Ollila, D.W.1
Essner, R.2
Wanek, L.A.3
Morton, D.L.4
-
10
-
-
33748573355
-
Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival
-
Neuber K, Eidam B: Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival. Onkologie 2006;29(8-9):361-5.
-
(2006)
Onkologie
, vol.29
, Issue.8-9
, pp. 361-365
-
-
Neuber, K.1
Eidam, B.2
|